Table 2 Up-to-date antigen wise coverage at 12 months of age in study participants by allocation group
| Â | Intervention A: Adapted Alma Sana Bracelet | Intervention B: Star Bracelet | Control | |||
|---|---|---|---|---|---|---|
Total Number of Children, n (%) | 482 | Â | 482 | Â | 481 | Â |
At BCG | 217/482 | (45.0) | 200/482 | (41.5) | 216/481 | (44.9) |
At Pentavalent-1 | 265/482 | (55.0) | 282/482 | (58.5) | 265/481 | (55.1) |
Pentavalent-1* | 208/217 | (95.8) | 183/200 | (91.5) | 202/216 | (93.5) |
Pentavalent-2 | 445/482 | (92.3) | 434/482 | (90.0) | 432/481 | (89.6) |
Pentavalent-3 | 408/482 | (84.6) | 411/481 | (85.4) | 399/481 | (83.0) |
Measles-1 | 345/479 | (72.0) | 339/481 | (70.5) | 329/480 | (68.5) |